Hepatitis B Screening Urged for Patients Undergoing Chemo, Immunotherapy
To prevent reactivation, antiviral therapy recommended for chemotherapy, immunotherapy patients who are hepatitis B positive.
Diagnosis & Disease Information
Activating CD103+ Dendritic Cells May Lead to Improved Immunotherapy for Variety of Cancers
Researchers delineated the intratumoral dendritic cells population and identified CD103+ DCs, extremely sparse yet remarkably capable cytotoxic T cell (CTL) stimulators.
Preclinical Study Identifies Potential Immunochemotherapeutic Option for Pancreatic Cancer
Researchers discovered a potentially safe and effective novel treatment for pancreatic cancer.
Researchers Identify Neo-Antigens as Potential Targets for Personalized Immunotherapy
Researchers identified potential new targets for personalized cancer vaccines.
PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy
[Cancer Control] Immunotherapeutic approaches to treating cancer have been evaluated during the last few decades with limited success.
Novel Method May Identify Melanoma Immunotherapy Targets
Researchers were able to identify mutated tumor targets that will improve the efficacy of adoptive T-cell therapy in patients with metastatic melanoma.
Interleukin-2 Immunotherapy Beneficial in Kidney Cancer
Recently published data indicates that patients with metastatic kidney cancer can benefit from high-dose IL-2 immunotherapy.
Vaccine Targeting Dendritic Cells Produces Robust Immunity in Advanced Cancer
An innovative approach to cancer treatment through dendritic cell vaccination has shown promise in eliciting immune responses to attack cancer cells.
Clifford Hudis, MD, on Important Advances During His Presidency
Clifford Hudis, MD, discusses advances in immunotherapy, which he views as one of the biggest breakthroughs in oncology during his tenure as president of the American Society of Clinical Oncology.
Autoimmune Endocrinopathies: Clinician and Patient Awareness, Communication Are Key
As immune checkpoint inhibitors come into wider clinical use, previously rare and potentially life-threatening immune-mediated endocrine system reactions may become more common.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...